Dysregulated PRL/PRLR or GH/GHR activity has been associated with the development of various cancers, including breast cancer (Wagner and Rui, 2008; Goffin and Touraine, 2015; Xu et al., 2013). This evidence concerns the gene GH1 and breast carcinoma.